Catalyst Pharmaceuticals, Inc. - Common Stock — Quarterly Cash Flow (NASDAQ:CPRX) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Total assets 908.87 M971.91 M1.05 B1.1 B1.15 B Total liabilities 114.59 M115.89 M131.36 M149.71 M134.91 M Total equity 794.28 M856.03 M920.25 M954.27 M1.01 B Total liabilities & shareholders' equities 908.87 M971.91 M1.05 B1.1 B1.15 B Total debt ————— Net debt —————

News

CPRX's Agamree Shows Potential Beyond DMD After Positive Phase I Data

Catalyst (CPRX) Up 0.6% Since Last Earnings Report: Can It Continue?

Why Catalyst Pharmaceutical (CPRX) is a Top Momentum Stock for the Long-Term

Why Catalyst Pharmaceutical (CPRX) is a Top Value Stock for the Long-Term

CPRX or UTHR: Which Is the Better Value Stock Right Now?

Catalyst Pharmaceuticals Q1 Earnings Beat, Firdapse Revenues Rise Y/Y

Catalyst (CPRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Catalyst Pharmaceutical (CPRX) Surpasses Q1 Earnings and Revenue Estimates

Perrigo Q1 Earnings Surpass Estimates, Sales Miss, Both Fall Y/Y

UTHR Q1 Earnings Miss Estimates, Shares Jump on Strong Outlook

ACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales Growth

Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up